LEUKOCARE continues to expand and invests in research and development(more...)
Rentschler and Leukocare announce strategic alliance and equity investment(more...)
LEUKOCARE grants license to US vaccine company PaxVax(more...)
Dr. Andreas Rummelt, pharma industry expert and former CEO of Sandoz, was elected as new supervisory board member at LEUKOCARE’s annual shareholder meeting on July 12th.
PloS ONE2014 December, PLoS ONE 9(12): e115940. doi:10.1371/journal.pone.
WINDOLF C.D. ET AL.: Lysostaphin-Coated Titan-Implants Preventing Localized Osteitis by Staphyloccus aureus in a Mouse Model (more...)
Human Vaccines & Immunotherapeutics2014 July; Vol. 10, Issue 10, Meeting Report
DERWAND R.: Annual World Vaccine Congress 2014: A re-evaluation of the value proposition for increasing vaccine thermostability (more...)
Vaccine2014 April; Vol. 32, Issue 19
SCHERLIESS R. ET AL.: Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates
Materials Today2012 September; Vol. 15, Number 9
TSCHELIESSNIG R. ET AL.: Nano-coating protects biofunctional materials(more...)